- New book: Why people are the ultimate resource.
- Subsidizing kids: Hungary exempts mothers of four or more children from income taxes for life. (The Economist, gated)
- Why do we need an Advanced Research Projects Agency-Health? Because the National Institutes of Health is too cautious. (NYT, gated)
- Life expectancy in China surpasses the US.
- Biden’s student loan debt forgiveness program is worse than you think.
- The right way to pay tuition for students who need a loan.
Category: Drug Prices & Regulations
Tuesday Links
- Climate anxiety is a mental health problem.
- Biden: the pandemic is over, but not his emergency Covid powers.
- IRS is about to end the Obamacare “family glitch” by re-wring then law. (gated)
- The CDC has lost the public’s confidence. Is the answer to give it more money?
- The 340b program was supposes to support drug therapy for low-oncome patients. Hospitals are using it to rip us off.
- Why don’t men get more vasectomies?
Monday Links
- CRISPR isn’t just for editing human genes. It can be used to increase corn and rice yields by 10%.
- Finally: the masks are coming off in Head Start.
- How would you like to be an inch or so taller? Doctors can oblige you.
- Learning loss was greatest in school districts that remained remote the longest.
- More on Rand Paul v. Anthony Fauci.
- Why its hard to know which drugs work best against Covid.
Drug Makers File Hundreds of Bogus Patents to Block Generic Competition
A report by the Initiative for Medicines, Access & Knowledge (I-MAK) released a report on patent abuse and so-called gaming of the patent system. I-MAK is a nonprofit organization that advocates drug patent reform.
Four pharmaceutical companies have filed hundreds of patents to keep their drugs out of the hands of generic competition and prolong their “unprecedented profits,” according to a report published Thursday.